Bio-Rad Laboratories | BIO - Debt



Bio-Rad Laboratories reported $1.41B in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Abbott USD 13.44B 195M Jun/2025
Agilent USD 3.41B 86M Jul/2025
Becton, Dickinson and Co. USD 19.34B 71M Jun/2025
Bio Techne USD 346M 16M Jun/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Bruker USD 2.44B 321.5M Jun/2025
Charles River Laboratories USD 2.79B 275.28M Jun/2025
Danaher USD 17.36B 878M Jun/2025
Exact Sciences USD 2.32B 16.28M Jun/2025
General Electric Aerospace USD 18.89B 684M Jun/2025
Hologic USD 2.52B 8.5M Jun/2025
Illumina USD 2.6B 608M Jun/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Laboratory Of America USD 6.52B 107.7M Mar/2025
Merck USD 34.84B 2.27B Mar/2025
Mettler Toledo International USD 2.18B 109.83M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Siemens EUR 57.52B 7.64B Mar/2025
Standard Biotools USD 28.62M 28.32M Jun/2025
Thermo Fisher Scientific USD 34.19B 2.91B Mar/2025
Tosoh JPY 179.1B 25.51B Mar/2025
Waters USD 1.54B 81.64M Jun/2025